XML 52 R30.htm IDEA: XBRL DOCUMENT
v2.4.0.6

Acquisitions (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2012
Thomas Medical Products, Inc [Member] |
Business Acquisition [Line Items] |
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block] | The total purchase price was preliminarily allocated as follows (in thousands):
Assets Acquired |
Trade receivables | $ | 6,507 |
Inventories | 5,459 |
Prepaid expenses | 340 |
Property and equipment | 2,685 |
Intangibles |
Developed technology | 43,000 |
Non-compete agreements | 500 |
Customer lists | 5,000 |
Trademarks | 1,400 |
Goodwill | 102,407 |
Total assets acquired | 167,298 |
Liabilities Assumed |
Trade payables | 588 |
Accrued expenses | 1,094 |
Total liabilities assumed | 1,682 |
Net assets acquired, net of cash acquired of $1,829 | $ | 165,616 |
Business Acquisition, Pro Forma Information [Table Text Block] | The following table summarizes our unaudited consolidated results of operations for the years ended December 31, 2012 and 2011, as well as unaudited pro forma consolidated results of operations as though the Thomas Medical, MediGroup and Ostial acquisitions had occurred on January 1, 2011 (in thousands, except per common share amounts):
| 2012 |  | 2011
| As Reported |  | Pro Forma |  | As Reported |  | Pro Forma
Net sales | $ | 394,288 |  |  | $ | 431,861 |  |  | $ | 359,449 |  |  | $ | 396,767 |
Net income | 19,710 |  |  | 24,296 |  |  | 23,044 |  |  | 22,033 |
Earnings per common share: |  |  |  |  |  |  |
Basic | $ | 0.47 |  |  | $ | 0.58 |  |  | $ | 0.59 |  |  | $ | 0.56 |
Diluted | $ | 0.46 |  |  | $ | 0.57 |  |  | $ | 0.58 |  |  | $ | 0.55 |
MediGroup [Member] |
Business Acquisition [Line Items] |
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block] | The total purchase price, which includes the contingent consideration liability described above, was preliminarily allocated as follows (in thousands):
Assets Acquired |
Inventories | $ | 263 |
Property and equipment | 79 |
Intangibles |
Developed technology | 2,000 |
Non-compete agreements | 210 |
Customer lists | 110 |
Trademarks | 80 |
Goodwill | 1,697 |
Total assets acquired | $ | 4,439 |
Ostial Solutions, LLC [Member] |
Business Acquisition [Line Items] |
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block] | It is not practical to separately report the earnings related to the Ostial acquisition, as we cannot split out sales costs related to Ostial products, principally because our sales representatives are selling multiple products (including Ostial products) in the cardiovascular business segment. The total purchase price, which includes the contingent consideration liability described above, was allocated as follows (in thousands):
Assets Acquired |
Intangibles |
Developed technology | $ | 10,500 |
Customer lists | 600 |
Trademark | 110 |
Non-compete agreements | 10 |
Goodwill | 9,580 |
Total assets acquired | $ | 20,800 |
Ash [Member] |
Business Acquisition [Line Items] |
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block] | The total purchase price, which includes the contingent consideration liability described above, was allocated as follows (in thousands):
Assets Acquired |
Property and equipment | $ | 73 |
Intangibles |
Developed technology | 3,200 |
Customer lists | 300 |
Goodwill | 2,697 |
Total assets acquired | $ | 6,270 |
BioSphere [Member] |
Business Acquisition [Line Items] |
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block] | As of December 31, 2010, the BioSphere purchase price was allocated as follows (in thousands):
Assets Acquired |  |
Marketable securities | $ | 9,673 |
Trade receivables | 4,529 |
Inventories | 5,694 |
Other assets | 1,340 |
Property and equipment | 546 |
Deferred income tax assets | 16,012 |
Intangibles |  |
Developed technology | 19,000 |
Customer list | 7,900 |
License agreement | 380 |
Trademark | 3,200 |
Goodwill | 34,016 |
Total assets acquired | 102,290 |
Liabilities Assumed |  |
Accounts payable | 322 |
Accrued expenses | 3,617 |
Deferred income tax liabilities | 729 |
Liabilities related to unrecognized tax benefits | 961 |
Other liabilities | 936 |
Total liabilities assumed | 6,565 |
Net assets acquired, net of cash acquired of $274 | $ | 95,725 |
Business Acquisition, Pro Forma Information [Table Text Block] | The following table summarizes our consolidated results of operations for the year ended December 31, 2010, as well as the pro forma consolidated results of operations as though the BioSphere acquisition had occurred on January 1, 2010 (in thousands, except per share amounts):
|  | Year Ended December 31, 2010
|  | As Reported |  | Pro Forma
Sales |  | $ | 296,755 |  |  | $ | 317,382 |
Net income |  | 12,460 |  |  | 7,258 |
Earnings per common share: |  |  |  |  |  |
Basic |  | $ | 0.35 |  |  | $ | 0.21 |
Diluted |  | $ | 0.35 |  |  | $ | 0.20 |

X
- Details
Name: | us-gaap_BusinessAcquisitionLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(2)-(3) -URI http://asc.fasb.org/extlink&oid=7659399&loc=d3e1392-128463 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 141 -Paragraph 54 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 141 -Paragraph 55 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 141R -Paragraph 68 -Subparagraph r(2, 3) -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. + Details
Name: | us-gaap_BusinessAcquisitionProFormaInformationTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6910749&loc=d3e4845-128472 + Details
Name: | us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration